Lipopolysaccharide lipid A phosphate group (LPS lipid A phosphate)

The lipopolysaccharide (LPS) lipid A phosphate groups are essential anionic moieties located on the surface of Gram-negative bacteria. These groups, typically found at the 1 and 4' positions of the glucosamine backbone of lipid A, are crucial for the structural stability of the bacterial outer membrane by sequestering divalent cations such as Mg2+ and Ca2+ (PubMed: 24511215). This interaction creates a tight, impermeable barrier against hydrophobic molecules and many antibiotics. In medicine, these phosphate groups are the primary pharmacological target for polymyxin antibiotics, including polymyxin B and colistin (StatPearls: NBK557775). The cationic nature of these drugs allows them to electrostatically bind to the negatively charged phosphates, displacing the stabilizing cations and leading to membrane permeabilization and bacterial lysis. Furthermore, the phosphate groups are vital for the recognition of LPS by the human immune system via the TLR4/MD-2 complex, which can lead to the release of pro-inflammatory cytokines and, in severe cases, septic shock (PubMed: 11544354). Consequently, targeting or neutralizing these groups is a key strategy in treating multidrug-resistant Gram-negative infections and managing sepsis.

Other names

Lipid A phosphateLPS phosphateEndotoxin phosphate group1-phosphate and 4'-phosphate of lipid ALipopolysaccharide phosphate

Cationic drugs bind electrostatically to the negatively charged phosphate groups of lipid A, displacing stabilizing divalent cations (Mg2+ and Ca2+), which leads to outer membrane disruption and increased permeability.